Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Abbisko Therapeutics' FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma

Summary by WBOC 16
SHANGHAI, March 31, 2026

19 Articles

WBOC 16WBOC 16
+18 Reposted by 18 other sources
Center

Abbisko Therapeutics' FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma

SHANGHAI, March 31, 2026

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 55% of the sources are Center
55% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Wednesday, April 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Shanghai, China icon

Shanghai, China

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal